Thakkar S, Anklam E, Xu A, Ulberth F, Li J, Li B, et al. Regulatory landscape of dietary supplements and herbal medicines from a global perspective. Regul Toxicol Pharmacol. 2020;114: 104647.
World Health Organization. WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems. Updated 2004. https://apps.who.int/iris/bitstream/handle/10665/43034/9241592214_eng.pdf. Accessed 5 Sep 2024.
Directive 2004/24/EC of the European Parliament and of the Council. https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:136:0085:0090:en:PDF. Accessed 5 Sep 2024.
Frye JC. Herbal and homeopathic medicine: understanding the difference. Semin Integr Med. 2003;1(3):158–66.
Barnes J. Pharmacovigilance of herbal medicines : a UK perspective. Drug Saf. 2003;26(12):829–51.
European Medicines Agency. Herbal medicinal products. https://www.ema.europa.eu/en/human-regulatory-overview/herbal-medicinal-products. Accessed 5 Sep 2024.
van Hunsel F, van der Kooi D, van de Koppel S, Kroes BH, Woerdenbag HJ. Analysis of reports on adverse drug reactions related to herbal medicinal products and herbal supplements in the Netherlands received by the National Pharmacovigilance Centre Lareb. Drug Saf. 2022;45(6):651–61.
Barnes J. Pharmacovigilance for herbal and traditional medicines. Cham: Adis International Ltd.; 2022.
European Medicines Agency. Pharmacovigilance: overview. https://www.ema.europa.eu/en/human-regulatory/overview/pharmacovigilance-overview. Accessed 5 Sep 2024.
Rodrigues E, Barnes J. Pharmacovigilance of herbal medicines: the potential contributions of ethnobotanical and ethnopharmacological studies. Drug Saf. 2013;36(1):1–12.
Shaw D, Graeme L, Pierre D, Elizabeth W, Kelvin C. Pharmacovigilance of herbal medicine. J Ethnopharmacol. 2012;140(3):513–8.
Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014;4:177.
Article PubMed PubMed Central Google Scholar
Walji R, Boon H, Barnes J, Austin Z, Baker GR, Welsh S. Adverse event reporting for herbal medicines: a result of market forces. Healthc Policy. 2009;4(4):77–90.
PubMed PubMed Central Google Scholar
Thomas DR. A general inductive approach for analyzing qualitative evaluation data. Am J Eval. 2006;27(2):237–46.
Campbell S, Greenwood M, Prior S, Shearer T, Walkem K, Young S, et al. Purposive sampling: complex or simple? Research case examples. J Res Nurs. 2020;25(8):652–61.
Article PubMed PubMed Central Google Scholar
Klerings I, Robalino S, Booth A, Escobar-Liquitay CM, Sommer I, Gartlehner G, et al. Rapid reviews methods series: guidance on literature search. BMJ Evid Based Med. 2023;28(6):412.
Article PubMed PubMed Central Google Scholar
Wiarda S. Best practices of pharmacovigilance of herbal medicinal products. University of Groningen; 2022. https://fse.studenttheses.ub.rug.nl/27285/. Accessed 5 Sep 2024.
International Society of Pharmacovigilance. Special interest groups: herbal and traditional medicines group. https://isoponline.org/special-interest-groups/herbal-and-traditional-medicines-2/. Accessed 5 Sep 2024.
ANSES. Nutrivigilance. https://www.anses.fr/fr/content/tout-savoir-sur-le-dispositif-de-nutrivigilance. Accessed 5 Sep 2024.
Crouse T, Lowe PA. The SAGE encyclopedia of educational research, measurement, and evaluation. Thousand Oaks (CA): SAGE Publications, Inc.; 2018. https://sk.sagepub.com/reference/sage-encyclopedia-of-educational-research-measurement-evaluation. Accessed 5 Sep 2024.
Kirchherr J, Charles K. Enhancing the sample diversity of snowball samples: recommendations from a research project on anti-dam movements in Southeast Asia. PLoS ONE. 2018;13(8): e0201710.
Article PubMed PubMed Central Google Scholar
Glaser B, Strauss A. Discovery of grounded theory: strategies for qualitative research (1st ed.). Routledge. 1999. https://doi.org/10.4324/9780203793206
Guest G, Namey E, Chen M. A simple method to assess and report thematic saturation in qualitative research. PLoS ONE. 2020;15(5): e0232076.
Article CAS PubMed PubMed Central Google Scholar
Hennink MM, Kaiser BN. Saturation in qualitative research. London. 2019. https://methods-sagepub-com-christuniversity.knimbus.com/foundations/saturation-in-qualitative-research. Accessed 5 Sep 2024.
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.
Sundler AJ, Lindberg E, Nilsson C, Palmér L. Qualitative thematic analysis based on descriptive phenomenology. Nurs Open. 2019;6(3):733–9.
Article PubMed PubMed Central Google Scholar
NVivo. https://www.nvivo.nl/. Accessed 5 Sep 2024.
AlYahmady HH, Alabri SS. Using Nvivo for data analysis in qualitative research. Int Interdiscip J Educ. 2013;2:181–6.
Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–57.
Alghamdi W, Al-Fadel N, Alghamdi EA, Alghamdi M, Alharbi F. Signal detection and assessment of herb-drug interactions: Saudi Food and Drug Authority experience. Drugs Real World Outcomes. 2023;10(4):577–85.
Article PubMed PubMed Central Google Scholar
Khan LM, Al-Harthi SE, Osman AM, Sattar MA, Ali AS. Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions. Saudi Pharm J. 2016;24(4):485–93.
European Medicines Agency. Signal management. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/pharmacovigilance-post-authorisation/signal-management. Accessed 5 Sep 2024.
Biagi M, Pecorari R, Appendino G, Miraldi E, Magnano AR, Governa P, et al. Herbal products in Italy: the thin line between phytotherapy, nutrition and parapharmaceuticals; a normative overview of the fastest growing market in Europe. Pharmaceuticals (Basel). 2016;9(4):65.
de Boer A, Geboers L, van de Koppel S, van Hunsel F. Governance of nutrivigilance in the Netherlands: reporting adverse events of non-registered products. Health Policy. 2022;126(8):731–7.
Gouveia BG, Rijo P, Gonçalo TS, Reis CP. Good manufacturing practices for medicinal products for human use. J Pharm Bioallied Sci. 2015;7(2):87–96.
Article PubMed PubMed Central Google Scholar
Duraz AY, Khan SA. Knowledge, attitudes and awareness of community pharmacists towards the use of herbal medicines in muscat region. Oman Med J. 2011;26(6):451–3.
Article PubMed PubMed Central Google Scholar
Worakunphanich W, Suwankesawong W, Youngkong S, Thavorncharoensap M, Anderson C, Toh LS. Thai stakeholders’ awareness and perceptions of the patient adverse event reporting system for herbal medicines: a qualitative study. Int J Clin Pharm. 2023;45(2):491–501.
Article PubMed PubMed Central Google Scholar
Menniti-Ippolito F, Mazzanti G, Santuccio C, Moro PA, Calapai G, Firenzuoli F, et al. Surveillance of suspected adverse reactions to natural health products in Italy. Pharmacoepidemiol Drug Saf. 2008;17(6):626–35.
Skalli S. The Moroccan experience of implementing a university curriculum for the pharmacovigilance of herbal medicines (phytovigilance). Drug Saf. 2024;47(3):285–6.
Mponda J, Muula A, Choko A, Ajuwon A, Moody J. Consumption and adverse reaction reporting of herbal medicines among people living with HIV at university teaching hospitals in Blantyre, Malawi and Ibadan, Nigeria. Malawi Med J. 2024;36:13–22.
Article PubMed PubMed Central Google Scholar
Choudhury A, Singh PA, Bajwa N, Dash S, Bisht P. Pharmacovigilance of herbal medicines: concerns and future prospects. J Ethnopharmacol. 2023;309: 116383.
Article CAS PubMed Google Scholar
Kiguba R, Olsson S, Waitt C. Pharmacovigilance in low- and middle-income countries: a review with particular focus on Africa. Br J Clin Pharmacol. 2023;89(2):491–509.
Saokaew S, Suwankesawong W, Permsuwan U, Chaiyakunapruk N. Safety of herbal products in Thailand: an analysis of reports in the thai health product vigilance center database from 2000 to 2008. Drug Saf. 2011;34(4):339–50.
Comments (0)